img

Global Gabapentin Enacarbil Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Gabapentin Enacarbil Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Gabapentin enacarbil is an anticonvulsant and analgesic drug of the gabapentinoid class, and a prodrug to gabapentin. It was designed for increased oral bioavailability over gabapentin, and human trials showed it to produce extended release of gabapentin with almost twice the overall bioavailability, especially when taken with a fatty meal. Gabapentin enacarbil has passed human clinical trials for the treatment of restless legs syndrome, and initial results have shown it to be well tolerated and reasonably effective.
Gabapentin Enacarbil report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Gabapentin Enacarbil market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Post-Herpetic Neuralgia (PHN) and Restless Legs Syndrome (RLS) are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Gabapentin Enacarbil industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Gabapentin Enacarbil key manufacturers include Arbor Pharma, Astellas, GlaxoSmithKline, Glenmark Pharma, Pfizer, Depomed, Teva, Mylan and Novartis, etc. Arbor Pharma, Astellas, GlaxoSmithKline are top 3 players and held % sales share in total in 2022.
Gabapentin Enacarbil can be divided into Capsule and Tablet, etc. Capsule is the mainstream product in the market, accounting for % sales share globally in 2022.
Gabapentin Enacarbil is widely used in various fields, such as Post-Herpetic Neuralgia (PHN), Restless Legs Syndrome (RLS) and Others,, etc. Post-Herpetic Neuralgia (PHN) provides greatest supports to the Gabapentin Enacarbil industry development. In 2022, global % sales of Gabapentin Enacarbil went into Post-Herpetic Neuralgia (PHN) filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Gabapentin Enacarbil market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Arbor Pharma
Astellas
GlaxoSmithKline
Glenmark Pharma
Pfizer
Depomed
Teva
Mylan
Novartis
Apotex
Sun Pharmaceutical
Aurobindo Pharma
Intas
Amneal
Marksans Pharma
Alkem
Jiangsu Enhua
Jiangsu Hengrui
Sailike Pharma
Segment by Type
Capsule
Tablet

Segment by Application


Post-Herpetic Neuralgia (PHN)
Restless Legs Syndrome (RLS)
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Gabapentin Enacarbil market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Gabapentin Enacarbil, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Gabapentin Enacarbil industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Gabapentin Enacarbil in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Gabapentin Enacarbil introduction, etc. Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Gabapentin Enacarbil market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Gabapentin Enacarbil Market Overview
1.1 Gabapentin Enacarbil Product Overview
1.2 Gabapentin Enacarbil Market Segment by Type
1.2.1 Capsule
1.2.2 Tablet
1.3 Global Gabapentin Enacarbil Market Size by Type
1.3.1 Global Gabapentin Enacarbil Market Size Overview by Type (2024-2034)
1.3.2 Global Gabapentin Enacarbil Historic Market Size Review by Type (2024-2024)
1.3.3 Global Gabapentin Enacarbil Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Gabapentin Enacarbil Sales Breakdown by Type (2024-2024)
1.4.2 Europe Gabapentin Enacarbil Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Gabapentin Enacarbil Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Gabapentin Enacarbil Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Gabapentin Enacarbil Sales Breakdown by Type (2024-2024)
2 Global Gabapentin Enacarbil Market Competition by Company
2.1 Global Top Players by Gabapentin Enacarbil Sales (2024-2024)
2.2 Global Top Players by Gabapentin Enacarbil Revenue (2024-2024)
2.3 Global Top Players by Gabapentin Enacarbil Price (2024-2024)
2.4 Global Top Manufacturers Gabapentin Enacarbil Manufacturing Base Distribution, Sales Area, Product Type
2.5 Gabapentin Enacarbil Market Competitive Situation and Trends
2.5.1 Gabapentin Enacarbil Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Gabapentin Enacarbil Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gabapentin Enacarbil as of 2022)
2.7 Date of Key Manufacturers Enter into Gabapentin Enacarbil Market
2.8 Key Manufacturers Gabapentin Enacarbil Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Gabapentin Enacarbil Status and Outlook by Region
3.1 Global Gabapentin Enacarbil Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Gabapentin Enacarbil Historic Market Size by Region
3.2.1 Global Gabapentin Enacarbil Sales in Volume by Region (2024-2024)
3.2.2 Global Gabapentin Enacarbil Sales in Value by Region (2024-2024)
3.2.3 Global Gabapentin Enacarbil Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Gabapentin Enacarbil Forecasted Market Size by Region
3.3.1 Global Gabapentin Enacarbil Sales in Volume by Region (2024-2034)
3.3.2 Global Gabapentin Enacarbil Sales in Value by Region (2024-2034)
3.3.3 Global Gabapentin Enacarbil Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Gabapentin Enacarbil by Application
4.1 Gabapentin Enacarbil Market Segment by Application
4.1.1 Post-Herpetic Neuralgia (PHN)
4.1.2 Restless Legs Syndrome (RLS)
4.1.3 Others
4.2 Global Gabapentin Enacarbil Market Size by Application
4.2.1 Global Gabapentin Enacarbil Market Size Overview by Application (2024-2034)
4.2.2 Global Gabapentin Enacarbil Historic Market Size Review by Application (2024-2024)
4.2.3 Global Gabapentin Enacarbil Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Gabapentin Enacarbil Sales Breakdown by Application (2024-2024)
4.3.2 Europe Gabapentin Enacarbil Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Gabapentin Enacarbil Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Gabapentin Enacarbil Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Gabapentin Enacarbil Sales Breakdown by Application (2024-2024)
5 North America Gabapentin Enacarbil by Country
5.1 North America Gabapentin Enacarbil Historic Market Size by Country
5.1.1 North America Gabapentin Enacarbil Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Gabapentin Enacarbil Sales in Volume by Country (2024-2024)
5.1.3 North America Gabapentin Enacarbil Sales in Value by Country (2024-2024)
5.2 North America Gabapentin Enacarbil Forecasted Market Size by Country
5.2.1 North America Gabapentin Enacarbil Sales in Volume by Country (2024-2034)
5.2.2 North America Gabapentin Enacarbil Sales in Value by Country (2024-2034)
6 Europe Gabapentin Enacarbil by Country
6.1 Europe Gabapentin Enacarbil Historic Market Size by Country
6.1.1 Europe Gabapentin Enacarbil Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Gabapentin Enacarbil Sales in Volume by Country (2024-2024)
6.1.3 Europe Gabapentin Enacarbil Sales in Value by Country (2024-2024)
6.2 Europe Gabapentin Enacarbil Forecasted Market Size by Country
6.2.1 Europe Gabapentin Enacarbil Sales in Volume by Country (2024-2034)
6.2.2 Europe Gabapentin Enacarbil Sales in Value by Country (2024-2034)
7 Asia-Pacific Gabapentin Enacarbil by Region
7.1 Asia-Pacific Gabapentin Enacarbil Historic Market Size by Region
7.1.1 Asia-Pacific Gabapentin Enacarbil Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Gabapentin Enacarbil Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Gabapentin Enacarbil Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Gabapentin Enacarbil Forecasted Market Size by Region
7.2.1 Asia-Pacific Gabapentin Enacarbil Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Gabapentin Enacarbil Sales in Value by Region (2024-2034)
8 Latin America Gabapentin Enacarbil by Country
8.1 Latin America Gabapentin Enacarbil Historic Market Size by Country
8.1.1 Latin America Gabapentin Enacarbil Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Gabapentin Enacarbil Sales in Volume by Country (2024-2024)
8.1.3 Latin America Gabapentin Enacarbil Sales in Value by Country (2024-2024)
8.2 Latin America Gabapentin Enacarbil Forecasted Market Size by Country
8.2.1 Latin America Gabapentin Enacarbil Sales in Volume by Country (2024-2034)
8.2.2 Latin America Gabapentin Enacarbil Sales in Value by Country (2024-2034)
9 Middle East and Africa Gabapentin Enacarbil by Country
9.1 Middle East and Africa Gabapentin Enacarbil Historic Market Size by Country
9.1.1 Middle East and Africa Gabapentin Enacarbil Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Gabapentin Enacarbil Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Gabapentin Enacarbil Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Gabapentin Enacarbil Forecasted Market Size by Country
9.2.1 Middle East and Africa Gabapentin Enacarbil Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Gabapentin Enacarbil Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Arbor Pharma
10.1.1 Arbor Pharma Company Information
10.1.2 Arbor Pharma Introduction and Business Overview
10.1.3 Arbor Pharma Gabapentin Enacarbil Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Arbor Pharma Gabapentin Enacarbil Products Offered
10.1.5 Arbor Pharma Recent Development
10.2 Astellas
10.2.1 Astellas Company Information
10.2.2 Astellas Introduction and Business Overview
10.2.3 Astellas Gabapentin Enacarbil Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Astellas Gabapentin Enacarbil Products Offered
10.2.5 Astellas Recent Development
10.3 GlaxoSmithKline
10.3.1 GlaxoSmithKline Company Information
10.3.2 GlaxoSmithKline Introduction and Business Overview
10.3.3 GlaxoSmithKline Gabapentin Enacarbil Sales, Revenue and Gross Margin (2024-2024)
10.3.4 GlaxoSmithKline Gabapentin Enacarbil Products Offered
10.3.5 GlaxoSmithKline Recent Development
10.4 Glenmark Pharma
10.4.1 Glenmark Pharma Company Information
10.4.2 Glenmark Pharma Introduction and Business Overview
10.4.3 Glenmark Pharma Gabapentin Enacarbil Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Glenmark Pharma Gabapentin Enacarbil Products Offered
10.4.5 Glenmark Pharma Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Information
10.5.2 Pfizer Introduction and Business Overview
10.5.3 Pfizer Gabapentin Enacarbil Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Pfizer Gabapentin Enacarbil Products Offered
10.5.5 Pfizer Recent Development
10.6 Depomed
10.6.1 Depomed Company Information
10.6.2 Depomed Introduction and Business Overview
10.6.3 Depomed Gabapentin Enacarbil Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Depomed Gabapentin Enacarbil Products Offered
10.6.5 Depomed Recent Development
10.7 Teva
10.7.1 Teva Company Information
10.7.2 Teva Introduction and Business Overview
10.7.3 Teva Gabapentin Enacarbil Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Teva Gabapentin Enacarbil Products Offered
10.7.5 Teva Recent Development
10.8 Mylan
10.8.1 Mylan Company Information
10.8.2 Mylan Introduction and Business Overview
10.8.3 Mylan Gabapentin Enacarbil Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Mylan Gabapentin Enacarbil Products Offered
10.8.5 Mylan Recent Development
10.9 Novartis
10.9.1 Novartis Company Information
10.9.2 Novartis Introduction and Business Overview
10.9.3 Novartis Gabapentin Enacarbil Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Novartis Gabapentin Enacarbil Products Offered
10.9.5 Novartis Recent Development
10.10 Apotex
10.10.1 Apotex Company Information
10.10.2 Apotex Introduction and Business Overview
10.10.3 Apotex Gabapentin Enacarbil Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Apotex Gabapentin Enacarbil Products Offered
10.10.5 Apotex Recent Development
10.11 Sun Pharmaceutical
10.11.1 Sun Pharmaceutical Company Information
10.11.2 Sun Pharmaceutical Introduction and Business Overview
10.11.3 Sun Pharmaceutical Gabapentin Enacarbil Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Sun Pharmaceutical Gabapentin Enacarbil Products Offered
10.11.5 Sun Pharmaceutical Recent Development
10.12 Aurobindo Pharma
10.12.1 Aurobindo Pharma Company Information
10.12.2 Aurobindo Pharma Introduction and Business Overview
10.12.3 Aurobindo Pharma Gabapentin Enacarbil Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Aurobindo Pharma Gabapentin Enacarbil Products Offered
10.12.5 Aurobindo Pharma Recent Development
10.13 Intas
10.13.1 Intas Company Information
10.13.2 Intas Introduction and Business Overview
10.13.3 Intas Gabapentin Enacarbil Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Intas Gabapentin Enacarbil Products Offered
10.13.5 Intas Recent Development
10.14 Amneal
10.14.1 Amneal Company Information
10.14.2 Amneal Introduction and Business Overview
10.14.3 Amneal Gabapentin Enacarbil Sales, Revenue and Gross Margin (2024-2024)
10.14.4 Amneal Gabapentin Enacarbil Products Offered
10.14.5 Amneal Recent Development
10.15 Marksans Pharma
10.15.1 Marksans Pharma Company Information
10.15.2 Marksans Pharma Introduction and Business Overview
10.15.3 Marksans Pharma Gabapentin Enacarbil Sales, Revenue and Gross Margin (2024-2024)
10.15.4 Marksans Pharma Gabapentin Enacarbil Products Offered
10.15.5 Marksans Pharma Recent Development
10.16 Alkem
10.16.1 Alkem Company Information
10.16.2 Alkem Introduction and Business Overview
10.16.3 Alkem Gabapentin Enacarbil Sales, Revenue and Gross Margin (2024-2024)
10.16.4 Alkem Gabapentin Enacarbil Products Offered
10.16.5 Alkem Recent Development
10.17 Jiangsu Enhua
10.17.1 Jiangsu Enhua Company Information
10.17.2 Jiangsu Enhua Introduction and Business Overview
10.17.3 Jiangsu Enhua Gabapentin Enacarbil Sales, Revenue and Gross Margin (2024-2024)
10.17.4 Jiangsu Enhua Gabapentin Enacarbil Products Offered
10.17.5 Jiangsu Enhua Recent Development
10.18 Jiangsu Hengrui
10.18.1 Jiangsu Hengrui Company Information
10.18.2 Jiangsu Hengrui Introduction and Business Overview
10.18.3 Jiangsu Hengrui Gabapentin Enacarbil Sales, Revenue and Gross Margin (2024-2024)
10.18.4 Jiangsu Hengrui Gabapentin Enacarbil Products Offered
10.18.5 Jiangsu Hengrui Recent Development
10.19 Sailike Pharma
10.19.1 Sailike Pharma Company Information
10.19.2 Sailike Pharma Introduction and Business Overview
10.19.3 Sailike Pharma Gabapentin Enacarbil Sales, Revenue and Gross Margin (2024-2024)
10.19.4 Sailike Pharma Gabapentin Enacarbil Products Offered
10.19.5 Sailike Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Gabapentin Enacarbil Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Gabapentin Enacarbil Industrial Chain Analysis
11.4 Gabapentin Enacarbil Market Dynamics
11.4.1 Gabapentin Enacarbil Industry Trends
11.4.2 Gabapentin Enacarbil Market Drivers
11.4.3 Gabapentin Enacarbil Market Challenges
11.4.4 Gabapentin Enacarbil Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Gabapentin Enacarbil Distributors
12.3 Gabapentin Enacarbil Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Capsule
Table 2. Major Company of Tablet
Table 3. Global Gabapentin Enacarbil Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Gabapentin Enacarbil Sales by Type (2024-2024) & (K Units)
Table 5. Global Gabapentin Enacarbil Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Gabapentin Enacarbil Sales by Type (2024-2024) & (US& Million)
Table 7. Global Gabapentin Enacarbil Market Share in Value by Type (2024-2024)
Table 8. Global Gabapentin Enacarbil Price by Type (2024-2024) & (US$/Unit)
Table 9. Global Gabapentin Enacarbil Sales by Type (2024-2034) & (K Units)
Table 10. Global Gabapentin Enacarbil Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Gabapentin Enacarbil Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Gabapentin Enacarbil Sales Market Share in Value by Type (2024-2034)
Table 13. Global Gabapentin Enacarbil Price by Type (2024-2034) & (US$/Unit)
Table 14. North America Gabapentin Enacarbil Sales by Type (2024-2024) & (K Units)
Table 15. North America Gabapentin Enacarbil Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Gabapentin Enacarbil Sales (K Units) by Type (2024-2024)
Table 17. Europe Gabapentin Enacarbil Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Gabapentin Enacarbil Sales (K Units) by Type (2024-2024)
Table 19. Asia-Pacific Gabapentin Enacarbil Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Gabapentin Enacarbil Sales (K Units) by Type (2024-2024)
Table 21. Latin America Gabapentin Enacarbil Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Gabapentin Enacarbil Sales (K Units) by Type (2024-2024)
Table 23. Middle East and Africa Gabapentin Enacarbil Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Gabapentin Enacarbil Sales by Company (2024-2024) & (K Units)
Table 25. Global Gabapentin Enacarbil Sales Share by Company (2024-2024)
Table 26. Global Gabapentin Enacarbil Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Gabapentin Enacarbil Revenue Share by Company (2024-2024)
Table 28. Global Market Gabapentin Enacarbil Price by Company (2024-2024) & (US$/Unit)
Table 29. Global Gabapentin Enacarbil Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Gabapentin Enacarbil Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gabapentin Enacarbil as of 2022)
Table 32. Date of Key Manufacturers Enter into Gabapentin Enacarbil Market
Table 33. Key Manufacturers Gabapentin Enacarbil Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Gabapentin Enacarbil Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Gabapentin Enacarbil Sales by Region (2024-2024) & (K Units)
Table 37. Global Gabapentin Enacarbil Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Gabapentin Enacarbil Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Gabapentin Enacarbil Sales Market Share in Value by Region (2024-2024)
Table 40. Global Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 41. Global Gabapentin Enacarbil Sales by Region (2024-2034) & (K Units)
Table 42. Global Gabapentin Enacarbil Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Gabapentin Enacarbil Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Gabapentin Enacarbil Sales Market Share in Value by Region (2024-2034)
Table 45. Global Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 46. Global Gabapentin Enacarbil Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Gabapentin Enacarbil Sales by Application (2024-2024) & (K Units)
Table 48. Global Gabapentin Enacarbil Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Gabapentin Enacarbil Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Gabapentin Enacarbil Sales Market Share in Value by Application (2024-2024)
Table 51. Global Gabapentin Enacarbil Price by Application (2024-2024) & (US$/Unit)
Table 52. Global Gabapentin Enacarbil Sales by Application (2024-2034) & (K Units)
Table 53. Global Gabapentin Enacarbil Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Gabapentin Enacarbil Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Gabapentin Enacarbil Sales Market Share in Value by Application (2024-2034)
Table 56. Global Gabapentin Enacarbil Price by Application (2024-2034) & (US$/Unit)
Table 57. North America Gabapentin Enacarbil Sales by Application (2024-2024) (K Units)
Table 58. North America Gabapentin Enacarbil Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Gabapentin Enacarbil Sales by Application (2024-2024) (K Units)
Table 60. Europe Gabapentin Enacarbil Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Gabapentin Enacarbil Sales by Application (2024-2024) (K Units)
Table 62. Asia-Pacific Gabapentin Enacarbil Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Gabapentin Enacarbil Sales by Application (2024-2024) (K Units)
Table 64. Latin America Gabapentin Enacarbil Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Gabapentin Enacarbil Sales by Application (2024-2024) (K Units)
Table 66. Middle East and Africa Gabapentin Enacarbil Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Gabapentin Enacarbil Sales by Country (2024-2024) & (K Units)
Table 68. North America Gabapentin Enacarbil Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Gabapentin Enacarbil Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Gabapentin Enacarbil Sales Market Share in Value by Country (2024-2024)
Table 71. North America Gabapentin Enacarbil Sales by Country (2024-2034) & (K Units)
Table 72. North America Gabapentin Enacarbil Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Gabapentin Enacarbil Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Gabapentin Enacarbil Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Gabapentin Enacarbil Sales by Country (2024-2024) & (K Units)
Table 76. Europe Gabapentin Enacarbil Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Gabapentin Enacarbil Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Gabapentin Enacarbil Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Gabapentin Enacarbil Sales by Country (2024-2034) & (K Units)
Table 80. Europe Gabapentin Enacarbil Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Gabapentin Enacarbil Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Gabapentin Enacarbil Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Gabapentin Enacarbil Sales by Region (2024-2024) & (K Units)
Table 84. Asia-Pacific Gabapentin Enacarbil Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Gabapentin Enacarbil Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Gabapentin Enacarbil Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Gabapentin Enacarbil Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Gabapentin Enacarbil Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Gabapentin Enacarbil Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Gabapentin Enacarbil Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Gabapentin Enacarbil Sales by Country (2024-2024) & (K Units)
Table 92. Latin America Gabapentin Enacarbil Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Gabapentin Enacarbil Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Gabapentin Enacarbil Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Gabapentin Enacarbil Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Gabapentin Enacarbil Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Gabapentin Enacarbil Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Gabapentin Enacarbil Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Gabapentin Enacarbil Sales by Country (2024-2024) & (K Units)
Table 100. Middle East and Africa Gabapentin Enacarbil Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Gabapentin Enacarbil Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Gabapentin Enacarbil Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Gabapentin Enacarbil Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Gabapentin Enacarbil Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Gabapentin Enacarbil Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Gabapentin Enacarbil Sales Market Share in Value by Country (2024-2034)
Table 107. Arbor Pharma Company Information
Table 108. Arbor Pharma Introduction and Business Overview
Table 109. Arbor Pharma Gabapentin Enacarbil Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 110. Arbor Pharma Gabapentin Enacarbil Product
Table 111. Arbor Pharma Recent Development
Table 112. Astellas Company Information
Table 113. Astellas Introduction and Business Overview
Table 114. Astellas Gabapentin Enacarbil Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 115. Astellas Gabapentin Enacarbil Product
Table 116. Astellas Recent Development
Table 117. GlaxoSmithKline Company Information
Table 118. GlaxoSmithKline Introduction and Business Overview
Table 119. GlaxoSmithKline Gabapentin Enacarbil Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 120. GlaxoSmithKline Gabapentin Enacarbil Product
Table 121. GlaxoSmithKline Recent Development
Table 122. Glenmark Pharma Company Information
Table 123. Glenmark Pharma Introduction and Business Overview
Table 124. Glenmark Pharma Gabapentin Enacarbil Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 125. Glenmark Pharma Gabapentin Enacarbil Product
Table 126. Glenmark Pharma Recent Development
Table 127. Pfizer Company Information
Table 128. Pfizer Introduction and Business Overview
Table 129. Pfizer Gabapentin Enacarbil Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 130. Pfizer Gabapentin Enacarbil Product
Table 131. Pfizer Recent Development
Table 132. Depomed Company Information
Table 133. Depomed Introduction and Business Overview
Table 134. Depomed Gabapentin Enacarbil Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 135. Depomed Gabapentin Enacarbil Product
Table 136. Depomed Recent Development
Table 137. Teva Company Information
Table 138. Teva Introduction and Business Overview
Table 139. Teva Gabapentin Enacarbil Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 140. Teva Gabapentin Enacarbil Product
Table 141. Teva Recent Development
Table 142. Mylan Company Information
Table 143. Mylan Introduction and Business Overview
Table 144. Mylan Gabapentin Enacarbil Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 145. Mylan Gabapentin Enacarbil Product
Table 146. Mylan Recent Development
Table 147. Novartis Company Information
Table 148. Novartis Introduction and Business Overview
Table 149. Novartis Gabapentin Enacarbil Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 150. Novartis Gabapentin Enacarbil Product
Table 151. Novartis Recent Development
Table 152. Apotex Company Information
Table 153. Apotex Introduction and Business Overview
Table 154. Apotex Gabapentin Enacarbil Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 155. Apotex Gabapentin Enacarbil Product
Table 156. Apotex Recent Development
Table 157. Sun Pharmaceutical Company Information
Table 158. Sun Pharmaceutical Introduction and Business Overview
Table 159. Sun Pharmaceutical Gabapentin Enacarbil Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 160. Sun Pharmaceutical Gabapentin Enacarbil Product
Table 161. Sun Pharmaceutical Recent Development
Table 162. Aurobindo Pharma Company Information
Table 163. Aurobindo Pharma Introduction and Business Overview
Table 164. Aurobindo Pharma Gabapentin Enacarbil Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 165. Aurobindo Pharma Gabapentin Enacarbil Product
Table 166. Aurobindo Pharma Recent Development
Table 167. Intas Company Information
Table 168. Intas Introduction and Business Overview
Table 169. Intas Gabapentin Enacarbil Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 170. Intas Gabapentin Enacarbil Product
Table 171. Intas Recent Development
Table 172. Amneal Company Information
Table 173. Amneal Introduction and Business Overview
Table 174. Amneal Gabapentin Enacarbil Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 175. Amneal Gabapentin Enacarbil Product
Table 176. Amneal Recent Development
Table 177. Marksans Pharma Company Information
Table 178. Marksans Pharma Introduction and Business Overview
Table 179. Marksans Pharma Gabapentin Enacarbil Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 180. Marksans Pharma Gabapentin Enacarbil Product
Table 181. Marksans Pharma Recent Development
Table 182. Alkem Company Information
Table 183. Alkem Introduction and Business Overview
Table 184. Alkem Gabapentin Enacarbil Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 185. Alkem Gabapentin Enacarbil Product
Table 186. Alkem Recent Development
Table 187. Jiangsu Enhua Company Information
Table 188. Jiangsu Enhua Introduction and Business Overview
Table 189. Jiangsu Enhua Gabapentin Enacarbil Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 190. Jiangsu Enhua Gabapentin Enacarbil Product
Table 191. Jiangsu Enhua Recent Development
Table 192. Jiangsu Hengrui Company Information
Table 193. Jiangsu Hengrui Introduction and Business Overview
Table 194. Jiangsu Hengrui Gabapentin Enacarbil Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 195. Jiangsu Hengrui Gabapentin Enacarbil Product
Table 196. Jiangsu Hengrui Recent Development
Table 197. Sailike Pharma Company Information
Table 198. Sailike Pharma Introduction and Business Overview
Table 199. Sailike Pharma Gabapentin Enacarbil Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 200. Sailike Pharma Gabapentin Enacarbil Product
Table 201. Sailike Pharma Recent Development
Table 202. Key Raw Materials Lists
Table 203. Raw Materials Key Suppliers Lists
Table 204. Gabapentin Enacarbil Market Trends
Table 205. Gabapentin Enacarbil Market Drivers
Table 206. Gabapentin Enacarbil Market Challenges
Table 207. Gabapentin Enacarbil Market Restraints
Table 208. Gabapentin Enacarbil Distributors List
Table 209. Gabapentin Enacarbil Downstream Customers
Table 210. Research Programs/Design for This Report
Table 211. Key Data Information from Secondary Sources
Table 212. Key Data Information from Primary Sources
List of Figures
Figure 1. Gabapentin Enacarbil Product Picture
Figure 2. Global Gabapentin Enacarbil Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Gabapentin Enacarbil Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Gabapentin Enacarbil Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Capsule
Figure 6. Global Capsule Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Tablet
Figure 8. Global Tablet Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Global Gabapentin Enacarbil Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Gabapentin Enacarbil Sales Market Share by Type in 2022 & 2034
Figure 11. North America Gabapentin Enacarbil Sales Market Share in Volume by Type in 2022
Figure 12. North America Gabapentin Enacarbil Sales Market Share in Value by Type in 2022
Figure 13. Europe Gabapentin Enacarbil Sales Market Share in Volume by Type in 2022
Figure 14. Europe Gabapentin Enacarbil Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Gabapentin Enacarbil Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Gabapentin Enacarbil Sales Market Share in Value by Type in 2022
Figure 17. Latin America Gabapentin Enacarbil Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Gabapentin Enacarbil Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Gabapentin Enacarbil Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Gabapentin Enacarbil Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Gabapentin Enacarbil Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Gabapentin Enacarbil Revenue in 2022
Figure 23. Gabapentin Enacarbil Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Post-Herpetic Neuralgia (PHN)
Figure 25. Global Post-Herpetic Neuralgia (PHN) Sales YoY Growth (2024-2034) & (K Units)
Figure 26. Product Picture of Restless Legs Syndrome (RLS)
Figure 27. Global Restless Legs Syndrome (RLS) Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Others
Figure 29. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Global Gabapentin Enacarbil Sales by Application (2024-2034) & (US$ Million)
Figure 31. Global Gabapentin Enacarbil Sales Market Share by Application in 2022 & 2034
Figure 32. North America Gabapentin Enacarbil Sales Market Share in Volume by Application in 2022
Figure 33. North America Gabapentin Enacarbil Sales Market Share in Value by Application in 2022
Figure 34. Europe Gabapentin Enacarbil Sales Market Share in Volume by Application in 2022
Figure 35. Europe Gabapentin Enacarbil Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Gabapentin Enacarbil Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Gabapentin Enacarbil Sales Market Share in Value by Application in 2022
Figure 38. Latin America Gabapentin Enacarbil Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Gabapentin Enacarbil Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Gabapentin Enacarbil Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Gabapentin Enacarbil Manufacturing Cost Structure
Figure 43. Gabapentin Enacarbil Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries